Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice

Neuropharmacology

Volumn 37, Issue 12, 1998, Pages 1465-1473

  Thomsen, Christian ^a   Ole Dalby, Nils ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Epilepsy; Metabotropic glutamate receptor; Pentylenetetrazole; Seizures

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 1 AMINO 3 (PHOSPHONOMETHYLENE)CYCLOBUTYLENE CARBOXYLATE; EGLUMETAD; METABOTROPIC RECEPTOR; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; EPILEPSY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SYNAPTIC TRANSMISSION;

ANIMALS; CEREBRAL VENTRICLES; CYCLOLEUCINE; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; INDANS; INFUSIONS, PARENTERAL; MALE; MICE; MICE, INBRED STRAINS; PENTYLENETETRAZOLE; REACTION TIME; RESORCINOLS; SEIZURES;

EID: 0032402917     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00138-5     Document Type: Article

References (45)

1. Abdul-Ghani A.S., Attwell P.J.E., Kent N.S., Bradford H.F., Croucher M.J., Jane D.E. Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate-receptor agonist. Brain Res. 755:1997;202-212.
2. Allan R.D., Hanrahan J.R., Hambley T.W., Johnston G.A., Mewett K.N., Mitrovic A.D. Synthesis and activity of a potent N-methyl-D-aspartic acid agonist, trans-1-aminocyclobutane-1,3-dicarboxylic acid, and related phosphonic and carboxylic acids. J. Med. Chem. 33:1990;2905-2915.
3. Aronica E.M., Gorter J.A., Paupard M.C., Grooms S.Y., Bennett M.V.L., Zukin R.S. Status epilepticus-induced alterations in metabotropic glutamate-receptor expression in young and adult rats. J. Neurosci. 17:1997;8588-8595.
4. Attwell P.J.E., Kaura S., Sigala G., Bradford H.F., Croucher M.J., Jane D.E., Watkins J.C. Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate-receptor agonist. Brain Res. 698:1995;155-162.
5. Brabet I., Mary S., Bockaert J., Pin J.P. Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responses. Neuropharmacology. 34:1995;895-903.
6. 3H]-2-amino-4-phosphonobutyrate to L-glutamate-sensitive sites on rat brain synaptic membranes. Br. J. Pharmacol. 80:1983;355-364.
7. Chapman A., Meldrum B. Excitatory amino acids in epilepsy and novel anti-epileptic drugs. Epilepsy Res. Suppl. 3:1991;39-48.
8. Dalby N.O., Nielsen E.B. Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res. 28:1997;63-72.
9. Dalby N.O., Thomsen C. Modulation of seizure activity in mice by metabotropic glutamate receptor ligands. J. Pharmacol. Exp. Ther. 276:1996;516-522.
10. Davies J., Watkins J.C. Actions of D and L forms of 2-amino-5-phosphono-valerate and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Res. 235:1982;378-386.
11. 3H]-L-2-Amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a. Br. J. Pharmacol. 116:1995;3279-3287.
12. Ghauri M., Chapman A.G., Meldrum B.S. Convulsant and anticonvulsant actions of agonists and antagonists of group-III mGluRs. Neuroreport. 7:1996;1469-1474.
13. Glaum S.R., Miller R.J. Activation of metabotropic glutamate receptors produces reciprocal regulation of ionotropic glutamate and GABA responses in the nucleus of the tractus solitarius of the rat. J. Neurosci. 13:1993;1636-1641.
14. Glaum, S.R., Miller, R.J., 1994. Acute regulation of synaptic transmission by metabotropic glutamate receptors. In: Conn, P.J., Patel, J. (Eds.), The Metabotropic Glutamate Receptors. Humana Press, Totowa, pp. 147-172.
15. Harvey J., Collingridge G.L. Signal-transduction pathways involved in the acute potentiation of NMDA responses by 1S,3R-ACPD in rat hippocampal slices. Br. J. Pharmacol. 109:1993;1085-1090.
16. Hayashi Y., Tanabe Y., Aramori I., Masu M., Shimamoto K., Ohfune Y., Nakanishi S. Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 107:1992;539-543.
17. Johansen P.A., Robinson M.B. Identification of 2-amino-2-methyl-4-phosphonobutanoic acid as an antagonist at the mGlu4a receptor. Eur. J. Pharmacol. 290:1995;R1-R3.
18. Kingston A.E., Burnett J.P., Mayne N.G., Lodge D. Pharmacological analysis of 4-carboxyphenylglycine derivatives: comparison of effects on mGluR1a and mGluR5a subtypes. Neuropharmacology. 34:1995;887-894.
19. Kinoshita A., Ohishi H., Nomura S., Shigemoto R., Nakanishi S., Mizuno N. Presynaptic localization of a metabotropic glutamate receptor, mGluR4a, in the cerebellar cortex: a light and electron microscope study in the rat. Neurosci. Lett. 207:1996;199-202.
20. Klitgaard H., Laudrup P. Metabotropic excitatory amino acid receptor agonists selectively potentiate behavioral effects induced by ionotropic excitatory amino acid receptor agonists in mice. Eur. J. Pharmacol. 250:1993;9-13.
21. Laudrup P., Klitgaard H. Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice. Eur. J. Pharmacol. 250:1993;15-22.
22. Meldrum B.S. The role of glutamate in epilepsy and other CNS disorders. Neurology. 44:1994;S14-S23.
23. Merlin L.R., Wong R.K.S. Role of group I metabotropic glutamate receptors in the patterning of epileptiform activities in vitro. J. Neurophysiol. 78:1997;539-544.
24. Miyamoto M., Ishida M., Shinozaki H. Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat. Neuroscience. 77:1997;131-140.
25. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740) - a potent, selective, and orally-active group-2 metabotropic glutamate-receptor agonist possessing anticonvulsant and anxiolytic properties. J. Med. Chem. 40:1997;528-537.
26. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attuci S., Peruginelli F., Torregrossa S.A., Pellegrini-Giampietro D.E., Luneia R., Pellicciari R. Pharmacological characterization of 1-amino-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J. Pharmacol. Exp. Ther. 281:1997;721-729.
27. Neugebauer V., Keele N.B., Shinnick-Gallagher P. Epileptogenesis in-vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in-vitro. J. Neurosci. 17:1997;983-995.
28. Nielsen E.B., Suzdak P.D., Andersen K.E., Knutsen L.J.S., Sonnewald U., Braestrup C. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur. J. Pharmacol. 196:1991;257-266.
29. Pellicciari R., Marinozzi M., Natalini B., Costantino G., Luneia R., Giorgi G., Moroni F., Thomsen C. Synthesis and pharmacological characterization of all 16 stereoisomers of 2-(2′-carboxy-3′-phenylcyclopropyl)glycine: focus on (2s,1′s,2′s,3′r)-2-(2′-carboxy-3′-phenylcyclo-prop yl)glycine, a novel and selective group-II metabotropic glutamate receptors antagonist. J. Med Chem. 39:1996;2259-2269.
30. Pin J.-P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
31. Pook P.C.-K., Sunter D.C., Udvarhelyi P.M., Watkins J.C. Evidence for presynaptic depression of monosynaptic excitation in neonatal rat motoneurones by (1S,3S)- and (1S,3R)-ACPD. Exp. Physiol. 77:1992;529-532.
32. Porsche-Wiebking E. New N-methyl-D-aspartate antagonists for the treatment of stroke. Drug Dev. Res. 17:1989;367-375.
33. Sacaan A.I., Schoepp D.D. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci. Lett. 139:1992;77-82.
34. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci. 17:1997;7503-7522.
35. Shinozaki H., Ishida M., Shimamoto K., Ohfune Y. Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord. Br. J. Pharmacol. 98:1989;1213-1234.
36. Suzdak, P.D., Thomsen, C., Mulvihill, E.R., Kristensen, P., 1994. Molecular cloning, expression, and characterization of metabotropic glutamate receptor subtypes. In: Conn, P.J., Patel, J. (Eds.), The Metabotropic Glutamate Receptors. Humana Press, Totowa, pp. 1-30.
37. Suzuki K., Mori N., Kittaka H., Iwata Y., Yamada Y., Osonoe K., Niwa S. Anticonvulsant action of metabotropic glutamate-receptor agonists in kindled amygdala of rats. Neurosci. Lett. 204:1996;41-44.
38. Szabo G., Horvath E.J., Aranyi P. Paradoxical effects of 2-amino-4-phosphonobutanoic acid and other 2-amino-omega-phosphonoalkanoic acids on the N-methyl-D-aspartate receptor ion channel. Drug Dev. Res. 28:1993;516-521.
39. Tang E., Yip P.K., Chapman A.G., Jane D.E., Meldrum B.S. Prolonged anticonvulsant action of glutamate receptor agonists in inferior colliculus of genetically epilepsy-prone rats. Eur. J. Pharmacol. 327:1997;109-115.
40. Thomas N.K., Jane D.E., Tse H.W., Watkins J.C. α-Methyl derivatives of serine-O-phosphate as novel, selective competitive metabotropic glutamate-receptor antagonists. Neuropharmacology. 35:1996;637-642.
41. Thomsen C. The L-AP4 receptor. Gen. Pharmacol. 29:1997;151-158.
42. Thomsen C., Hansen L., Suzdak P.D. L-Glutamate uptake inhibitors may stimulate phosphoinositide hydrolysis in baby hamster kidney cells expressing mGluR1a via heteroexchange with L-glutamate without direct activation of mGluR1a. J. Neurochem. 63:1994;2038-2047.
43. Thomsen C., Bruno V., Nicoletti F., Marinozzi M., Pellicciari R. (2S,1′S,2′S,3′R)-2-(2′-Carboxy-3′-phenylcyclopropy l)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors. Mol. Pharmacol. 50:1996;6-9.
44. Tizzano J.P., Griffey K.I., Schoepp D.D. Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology. 34:1995;1063-1067.
45. Watkins J., Olverman H.J. Agonists and antagonists for excitatory amino acid receptors. Trends Neuroci. 10:1987;265-272.